losartan has been researched along with Endometrial Neoplasms in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "And the MTT assay was performed in endometrial cancer cells following anti-miR-155 and AGTR1 blocker (losartan) treatment, alone and in combination." | 1.38 | Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells. ( Bae, DS; Choi, CH; Choi, JJ; Kim, BG; Kim, TJ; Lee, JW; Lee, YY; Park, YA; Song, SY; Song, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CH | 1 |
| Park, YA | 1 |
| Choi, JJ | 1 |
| Song, T | 1 |
| Song, SY | 1 |
| Lee, YY | 1 |
| Lee, JW | 1 |
| Kim, TJ | 1 |
| Kim, BG | 1 |
| Bae, DS | 1 |
1 other study available for losartan and Endometrial Neoplasms
| Article | Year |
|---|---|
Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Combined Modality Therapy; Endometrial Neoplasms; Female; H | 2012 |